UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $98

Benzinga Newsdesk www.benzinga.com Negative 53.1%

Neg 53.1% Neu 0% Pos 0%

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $100 to $98.

Comments

No comments yet. Be the first!